Idrasil® is not a replacement for recreational cannabis users unless they truly want to transition from the euphoric use of cannabis to the analgesic and therapeutic benefits only. Idrasil® is for patients that want real natural relief from a full range of ailments or for patients who want to reduce/stop their existing pharmaceutical or over-the-counter regiments, related negative side effect or addictions.
A serious medical condition, as defined by SB 420, is any of the following: AIDS; anorexia; arthritis; cachexia; cancer; chronic pain; glaucoma; migraine; persistent muscle spasms; seizures; severe nausea; and any other chronic or a persistent medical symptom that substantially limits a person’s ability to conduct one or more of major life activities as defined in the Americans with Disabilities act of 1990. Also, any symptom that if not alleviated may cause serious harm to the person’s safety, physical, or mental health.
Idrasil® is a Aseptically Processed and Bacteria Free, all natural Nutraceutical
Main Ingredient: Proprietary Balanced Concentrate of Cannabis Extract including the full range of essential Cannabinoids
Other Ingredients: Calcium carbonate is widely used medicinally as an inexpensive dietary calcium supplement or gastric antacid it is also used in the pharmaceutical industry as an inert filler for tablets and other pharmaceuticals. (Gluten free)
Magnesium stearate is a magnesium salt containing stearic acid. Stearic acid is an 18 carbon long saturated fat, common in our food supply. It is readily metabolized to oleic acid (the monounsaturated fat found in olive oil). Stearic acid is unique among all saturated fatty acids because it does not raise LDL cholesterol levels. (Gluten free)
Dicalcium phosphate is mainly used as a dietary supplement in prepared breakfast cereals, enriched flour, and noodle products. It is also used as a tableting agent in some pharmaceutical preparations; it is also used in some toothpaste as a tartar control agent.(Gluten free)
Microcrystalline Cellulose is a commonly used excipient (An excipient is generally a pharmacologically inactive substance used as a carrier for the active ingredients of a pill) Microcrystalline cellulose is the same as cellulose, except that it meets USP standards. It is also found in many processed food products, and may be used as an anti-caking agent, stabilizer, texture modifier, or suspending agent among other uses. According to the Select Committee on GRAS Substances, microcrystalline cellulose is generally regarded as safe when used in normal quantities. (Gluten free)
Silicon Dioxide is a common additive in the production of foods, where it is used primarily as a flow agent in powdered foods.(Gluten free)
Yes. Idrasil® (Medical Cannabis) is legal within the confines of the state of CA according to multiple CA Medical Cannabis laws passed by the state. CA passed Proposition 215 in 1996 (The Compassionate Use Act) & CA Senate Bill 420 were written into law in 2003 to clarify the scope of the Act for CA patients, caregivers & law enforcement. For extensive State of California Info: C3® (Maker of Idrasil™) is a Mutual Benefit, Non-Profit Corporation organized under CA State Law in December 2009. C3® only provides Idrasil® to patients residing in California.
Idrasil® is not legally available anywhere outside CA.
C3® requires a Doctor’s prescription or recommendation accompanied by a valid CA driver license that will be verified before Idrasil® can be purchased.
Furthermore, it is legal to purchase medical cannabis from the internet per CA Health and Safety Code 11362.5 and CA Proposition 215.
No. The state prescription or recommendation system has safeguards to protect patient privacy. Patient names and addresses are not kept in the state’s database: the only information retained is a personal photo and ID number. The privacy of medical records is protected by federal HIPPA laws.
Not necessarily. The California Supreme Court ruled that employers can discriminate against medical cannabis users. The legislature passed a bill to change that in 2008, but Gov. Schwarzenegger vetoed it. In 2011 and 2012, support could not be found in the California Senate for medical cannabis users’ employment rights. If you are seriously contemplating using Idrasil®, we suggest talking with your HR department prior if you may be at risk.
C3® strictly follows HIPPA (Health Information Patient Privacy Act). All documents are received by HIPPA compliant secure fax and networks. C3® maintains all documents in HIPPA compliant, locked file cabinets.
We do not share any personal information with any other entity.
Your information has the same privacy as it would in a medical office.
There are two types of cannabinoid receptors in human tissues, CB1 and CB2. CB1 receptors are present in the brain and spinal cord and in certain peripheral tissues. CB2 receptors are expressed primarily in organ tissues. There is preliminary evidence to suggest that additional cannabinoid receptor types may exist.
Cannabinoids: Two cannabinoids to date have been well characterized – THC and CBD. Both THC and CBD have important pharmacology: THC has analgesic, anti-spasmodic, anti-tremor, anti-inflammatory, anti-emetic properties & as an appetite stimulant & creates satiation. CBD has anti-inflammatory, anti-convulsion, anti-psychotic, anti-oxidant, neuroprotective and immunomodulatory effects. CBD is not intoxicating and it has been suggested that the presence of CBD in cannabis may alleviate some of the potentially unwanted side-effects of THC. Additionally, CBN specifically targets pain relief, suppresses muscle spasms and aids sleep.
*Anecdotally, cannabis has been used by civilizations as medicine since earliest recorded time.
The nature of smoking or edible confections is such that they will always vary greatly from plant to plant & batch to batch, resulting in an inherent lack of consistency which leads to irregular analgesic or therapeutic results. Idrasil® will give the same standard & consistent results, dose to dose.
Idrasil™ will give a full range of analgesic and therapeutic benefits following your doctors prescribed dosage following our 6:1:6 rule.
Idrasil™ is sterile and bacteria free and processed in an ISO9001 certified laboratory.
Idrasil™ is odorless and looks like any other mainstream pill, with no social stigma attached. Idrasil™ offers convenient and discreet portability, for dosing cannabis, in a 25mg tablet.
Idrasil™ is a Complimentary Medical approach.
Dosing depends on if the patient has prior experience medicating with cannabis. Idrasil® is soluble and can be swallowed, crushed & put in food or drink.
A basic guideline for titrating your dose is start with 6.25 mg (1/4 of the pill) Increase your next dose by 6 mg till you find relief.
6.25:1:6 Rule > 6.25 mg/ per 100 lbs. Body Weight / per 6 hours
C3® makes your privacy and discretion a top priority. C3® follows strict HIPPA standards (Health Information Patient Privacy Act).
C3® members will be able to order online from the privacy of home so no one will discover you are a medical cannabis patient unless you tell someone.
C3® ships via UPS and packaging is unidentifiable. Credit card statements will only describe a charge from a C3® employee.
If you have recently joined the C3®, we may currently be in the process of verifying your information.
We cannot verify the information without our having received all the required documents, so if you have not sent the forms, please Fax, Email, Text, Photograph or U.S. Mail.
After you have been verified, we will send a confirmation email that you have been approved.
Only verified members can purchase Idrasil®.
C3® offers Free Medical Insurance Billing to your Insurance provider. Please refer to the Insurance section under Patient Information.
There are step by step instructions and information on how to get started.
What documentation do you need to bill insurance?
1. C3® Membership Forms
2. Valid CA Doctors A Written Prescription from your Doctor.
3. Valid CA ID
4. The front and back of your insurance card.
5. Send to our Patient Services Department by Fax +1 (855) 437-2779, Email [email protected] or Mail to:
13210 Harbor Blvd.,#187
Garden Grove, California 92843
No. Because of the HIPPA (Health Information Patient Privacy Act), your insurance company cannot share any of your medical information with your employer. Even though your employer provides the policy, they do not have any access to information divulging the nature of why any employees are billing their insurance.
Think of it this way: your employer picks the insurance plan for the employees and pays the premium, which is their only involvement.
C3® currently bills all individual and employer-provided policies.
Namely: Blue Shield, Blue Cross, PacifiCare, Aetna, Cigna, Universal Care & United Health Care, for both PPO’s and HMO’s.
C3® currently cannot bill Kaiser, Medi-Cal or Medi-Care.
The Insurance companies initial reaction is to deny a claim for any new product such as Idrasil®. C3® is the first company to successfully bill, and be paid, for medical cannabis in the history of the State of California. Idrasil™Idrasil® is new and the only pill of its kind available anywhere in the world.
Before Idrasil™, Doctors did not have a way to prescribe a set dose of cannabinoids so it was impossible to bill for medical cannabis.
C3 Patients Association will attempt to acquire a ‘Prior Authorization’ from your provider.
Medical cannabis is your legal alternative in California; C3 Patients Association tries very hard to have the insurance companies recognize Proposition 215 & pay all claims.
C3 Patients Association is paving the way for your legal right to use medical cannabis as an alternative to other, possibly dangerous or addictive, medications.
Once we have approval from your insurance company, future claims are paid within 30 days.